{"id":54415,"date":"2026-01-16T20:10:06","date_gmt":"2026-01-16T12:10:06","guid":{"rendered":"https:\/\/flcube.com\/?p=54415"},"modified":"2026-01-16T20:10:07","modified_gmt":"2026-01-16T12:10:07","slug":"gan-lees-insulin-glargine-wins-ethiopia-approval-challenging-sanofis-dominance","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=54415","title":{"rendered":"Gan &amp; Lee&#8217;s Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi&#8217;s Dominance"},"content":{"rendered":"\n<p><strong>Gan &amp; Lee Pharmaceuticals<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/603087:SHA\">SHA: 603087<\/a>) announced that its <strong>insulin glargine injection<\/strong> and <strong>pre\u2011filled insulin glargine injection pen<\/strong> have received approval from the <strong>Ethiopian Food and Drug Authority<\/strong>, marking the company&#8217;s entry into the African market and challenging Sanofi&#8217;s dominant position.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-milestone\">Regulatory Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Gan &amp; Lee Pharmaceuticals (603087.SH)<\/td><\/tr><tr><td><strong>Products<\/strong><\/td><td>Insulin glargine injection; Pre\u2011filled insulin glargine injection pen<\/td><\/tr><tr><td><strong>Approval<\/strong><\/td><td>Ethiopian Food and Drug Authority<\/td><\/tr><tr><td><strong>Indication<\/strong><\/td><td>Diabetes mellitus<\/td><\/tr><tr><td><strong>Approval Date<\/strong><\/td><td>14\u202fJan\u202f2026<\/td><\/tr><tr><td><strong>Market Status<\/strong><\/td><td>First Chinese insulin glargine in Ethiopia<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-drug-profile-amp-mechanism\">Drug Profile &amp; Mechanism<\/h2>\n\n\n\n<p><strong>Insulin glargine<\/strong> is a <strong>long\u2011acting basal insulin<\/strong> administered via <strong>once\u2011daily subcutaneous injection<\/strong>, providing <strong>24\u2011hour blood glucose\u2011lowering effects<\/strong> with:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Prolonged duration of action<\/strong><\/li>\n\n\n\n<li><strong>Stable blood concentration without peaks<\/strong><\/li>\n\n\n\n<li><strong>Consistent blood sugar control<\/strong><\/li>\n<\/ul>\n\n\n\n<p>This profile offers <strong>improved patient compliance<\/strong> and <strong>reduced hypoglycemia risk<\/strong> compared to intermediate\u2011acting insulins.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-opportunity-amp-competitive-landscape\">Market Opportunity &amp; Competitive Landscape<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>Ethiopia<\/th><th>Sanofi\u2019s Global Sales<\/th><\/tr><\/thead><tbody><tr><td><strong>Diabetes Prevalence<\/strong><\/td><td>5.2\u202fmillion<\/td><td>\u2013<\/td><\/tr><tr><td><strong>Insulin\u2011Dependent Patients<\/strong><\/td><td>420,000<\/td><td>\u2013<\/td><\/tr><tr><td><strong>Insulin Glargine Market Share<\/strong><\/td><td>100\u202f% (Sanofi)<\/td><td>\u2013<\/td><\/tr><tr><td><strong>Sanofi\u2019s Lantus 2024 Sales<\/strong><\/td><td>\u2013<\/td><td><strong>EUR\u202f2.855\u202fbillion<\/strong><\/td><\/tr><tr><td><strong>Gan &amp; Lee Pricing Strategy<\/strong><\/td><td>30\u202f% discount to Lantus<\/td><td>\u2013<\/td><\/tr><tr><td><strong>Addressable Market Value<\/strong><\/td><td><strong>USD\u202f45\u202fmillion<\/strong> (2030E)<\/td><td>\u2013<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Current Standard:<\/strong> Sanofi\u2019s Lantus is the <strong>sole supplier<\/strong> in Ethiopia\u2019s insulin glargine market<\/li>\n\n\n\n<li><strong>Unmet Need:<\/strong> Limited access to <strong>affordable basal insulin<\/strong> in sub\u2011Saharan Africa<\/li>\n\n\n\n<li><strong>Differentiation:<\/strong> Gan &amp; Lee\u2019s <strong>pre\u2011filled pen<\/strong> offers <strong>convenience<\/strong> at a <strong>lower cost<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-positioning\">Strategic Positioning<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Geographic Expansion:<\/strong> Marks Gan &amp; Lee\u2019s <strong>first regulatory approval in Africa<\/strong>, establishing a foothold in the <strong>fast\u2011growing diabetes market<\/strong><\/li>\n\n\n\n<li><strong>Manufacturing:<\/strong> Company\u2019s <strong>Beijing biologics facility<\/strong> (capacity 10,000\u202fL) will supply Ethiopia, with <strong>cold\u2011chain logistics partnerships<\/strong> already established<\/li>\n\n\n\n<li><strong>Pricing Advantage:<\/strong> <strong>30\u202f% discount<\/strong> to Sanofi\u2019s Lantus positions Gan &amp; Lee as a <strong>cost\u2011effective alternative<\/strong> in price\u2011sensitive markets<\/li>\n\n\n\n<li><strong>Revenue Forecast:<\/strong> Ethiopia launch expected <strong>Q2\u202f2026<\/strong>, projecting <strong>USD\u202f8\u202fmillion<\/strong> in first\u2011year sales and <strong>USD\u202f45\u202fmillion<\/strong> by 2030<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding market penetration, revenue forecasts, and competitive dynamics for Gan &amp; Lee\u2019s insulin glargine in Ethiopia. Actual results may differ due to pricing pressures, regulatory changes, and market access challenges.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/603087_20260116_CEGL.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 603087_20260116_CEGL.\"><\/object><a id=\"wp-block-file--media-23316794-1d7b-4a4e-9d05-360122f32272\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/603087_20260116_CEGL.pdf\">603087_20260116_CEGL<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/603087_20260116_CEGL.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-23316794-1d7b-4a4e-9d05-360122f32272\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Gan &amp; Lee Pharmaceuticals (SHA: 603087) announced that its insulin glargine injection and pre\u2011filled insulin&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,11],"tags":[39,421,15,1120],"class_list":["post-54415","post","type-post","status-publish","format-standard","hentry","category-company","category-drug","tag-diabetes","tag-gan-lee-pharmaceuticals","tag-product-approvals","tag-sha-603087"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Gan &amp; Lee&#039;s Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi&#039;s Dominance - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Gan &amp; Lee Pharmaceuticals (SHA: 603087) announced that its insulin glargine injection and pre\u2011filled insulin glargine injection pen have received approval from the Ethiopian Food and Drug Authority, marking the company&#039;s entry into the African market and challenging Sanofi&#039;s dominant position.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=54415\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gan &amp; Lee&#039;s Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi&#039;s Dominance\" \/>\n<meta property=\"og:description\" content=\"Gan &amp; Lee Pharmaceuticals (SHA: 603087) announced that its insulin glargine injection and pre\u2011filled insulin glargine injection pen have received approval from the Ethiopian Food and Drug Authority, marking the company&#039;s entry into the African market and challenging Sanofi&#039;s dominant position.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=54415\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-16T12:10:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-16T12:10:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54415#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54415\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Gan &amp; Lee&#8217;s Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi&#8217;s Dominance\",\"datePublished\":\"2026-01-16T12:10:06+00:00\",\"dateModified\":\"2026-01-16T12:10:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54415\"},\"wordCount\":356,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Diabetes\",\"Gan &amp; Lee Pharmaceuticals\",\"Product approvals\",\"SHA: 603087\"],\"articleSection\":[\"Company\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=54415#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54415\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=54415\",\"name\":\"Gan &amp; Lee's Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi's Dominance - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-01-16T12:10:06+00:00\",\"dateModified\":\"2026-01-16T12:10:07+00:00\",\"description\":\"Gan & Lee Pharmaceuticals (SHA: 603087) announced that its insulin glargine injection and pre\u2011filled insulin glargine injection pen have received approval from the Ethiopian Food and Drug Authority, marking the company's entry into the African market and challenging Sanofi's dominant position.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54415#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=54415\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54415#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gan &amp; Lee&#8217;s Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi&#8217;s Dominance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Gan &amp; Lee's Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi's Dominance - Insight, China&#039;s Pharmaceutical Industry","description":"Gan & Lee Pharmaceuticals (SHA: 603087) announced that its insulin glargine injection and pre\u2011filled insulin glargine injection pen have received approval from the Ethiopian Food and Drug Authority, marking the company's entry into the African market and challenging Sanofi's dominant position.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=54415","og_locale":"en_US","og_type":"article","og_title":"Gan &amp; Lee's Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi's Dominance","og_description":"Gan & Lee Pharmaceuticals (SHA: 603087) announced that its insulin glargine injection and pre\u2011filled insulin glargine injection pen have received approval from the Ethiopian Food and Drug Authority, marking the company's entry into the African market and challenging Sanofi's dominant position.","og_url":"https:\/\/flcube.com\/?p=54415","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-16T12:10:06+00:00","article_modified_time":"2026-01-16T12:10:07+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=54415#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=54415"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Gan &amp; Lee&#8217;s Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi&#8217;s Dominance","datePublished":"2026-01-16T12:10:06+00:00","dateModified":"2026-01-16T12:10:07+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=54415"},"wordCount":356,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Diabetes","Gan &amp; Lee Pharmaceuticals","Product approvals","SHA: 603087"],"articleSection":["Company","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=54415#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=54415","url":"https:\/\/flcube.com\/?p=54415","name":"Gan &amp; Lee's Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi's Dominance - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-01-16T12:10:06+00:00","dateModified":"2026-01-16T12:10:07+00:00","description":"Gan & Lee Pharmaceuticals (SHA: 603087) announced that its insulin glargine injection and pre\u2011filled insulin glargine injection pen have received approval from the Ethiopian Food and Drug Authority, marking the company's entry into the African market and challenging Sanofi's dominant position.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=54415#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=54415"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=54415#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Gan &amp; Lee&#8217;s Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi&#8217;s Dominance"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=54415"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54415\/revisions"}],"predecessor-version":[{"id":54418,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54415\/revisions\/54418"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=54415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=54415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=54415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}